MacroGenics
MGNX
#9385
Rank
โ‚น7.94 B
Marketcap
โ‚น125.59
Share price
-1.07%
Change (1 day)
-54.15%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): -โ‚น4.98

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น4.53. In 2024 the company made an earnings per share (EPS) of -โ‚น97.03 a decrease over its 2023 EPS that were of -โ‚น13.60.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น4.98-94.87%
2024-โ‚น97.03613.33%
2023-โ‚น13.60-92.31%
2022-โ‚น176.82-42.14%
2021-โ‚น305.5836.44%
2020-โ‚น223.97-21.84%
2019-โ‚น286.54-24.58%
2018-โ‚น379.94675.93%
2017-โ‚น48.97-68.05%
2016-โ‚น153.25168.25%
2015-โ‚น57.13-55%
2014-โ‚น126.953400%
2013-โ‚น3.63-108.68%
2012โ‚น41.8024.49%
2011โ‚น33.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Xencor
XNCR
-โ‚น160.50 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น155.97-3,540.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น688.59-15,287.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น591.22-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,182-26,160.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น1,861-41,136.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น269.31-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA